Resultados de la búsqueda 21-30 of 15310 for Adhesion

  1. Placenta adherida - Síntomas y causas - Mayo Clinic

    También es posible que la placenta invada los músculos del útero (placenta increta) o crezca a través de la pared uterina (placenta percreta). Placenta normal y ...

  2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

  3. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  4. Centro Pediátrico de Mayo Clinic - Ensayos clínicos

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

  5. Ensayos clínicos - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

  6. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  7. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  8. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  10. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...